Roivant Sciences vs Tvardi Therapeutics
ROIV and TVRD side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ROIV and TVRD compare
Roivant Sciences is the larger company, worth 2521 times as much as Tvardi Therapeutics ($26.7B against $10.6M).
Roivant Sciences scores higher on the StockData Score (7 against 6 for Tvardi Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ROIV | TVRD |
|---|---|---|
| Size and price | ||
| Market cap | $26.7B | $10.6M |
| Share price | $36.91 | $0.793 |
| Change, 1 year | 96.7% | −83.4% |
| Change, 5 years | 377% | −99.9% |
| Beta (5Y) | 0.86 | 1.10 |
| Employees | 721 | 12 |
| StockData Score | ||
| Total score | 7 (better) | 6 |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 6 (better) | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 3540× | – |
| P/B | 6.3× | 1.3× (better) |
| FCF yield | −3.1% | – |
| Growth | ||
| Revenue growth (TTM) | −67.6% | – |
| Revenue growth, 5Y average | −19.1% | – |
| Profitability | ||
| Operating margin | −7915% | – |
| Net margin | −3535% | – |
| FCF margin | −10901% | – |
| Return on equity | −6.2% (better) | −126% |
| Return on invested capital | −407% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 16.72 (better) | 1.87 |
| Altman Z-score | 41.99 (better) | −13.77 |
| Piotroski F-score | 2 (better) | 1 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 78.1% | 16.7% |
| Held by insiders | 14.3% | 15.6% |
| Insider net buying, 12 months | −$870M | – |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 6.3% | 2.0% |
Go deeper
- ROIV stock overview
- ROIV income statement
- ROIV valuation and score
- TVRD stock overview
- TVRD income statement
- TVRD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.